DJIA 16,915.07 -70.54 -0.42%
NASDAQ 4,396.20 -22.83 -0.52%
S&P 500 1,964.68 -8.15 -0.41%
market minute promo

Pain Therapeutics, Inc. (NASDAQ: PTIE)

5.02 -0.16 (-3.09%)

REAL-TIME: Last trade at

Extended Hours: $5.02 $0.00 (0.00%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

PTIE $5.02 -3.09%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.15
Previous Close $5.18
Daily Range $4.90 - $5.19
52-Week Range $2.16 - $6.22
Market Cap $228.9M
P/E Ratio 8.41
Dividend (Yield) $0.00 (0.0%)
Volume 274,380
Average Daily Volume 410,017
Current FY EPS -$0.30





Pain Therapeutics, Inc. (PTIE) Description

A biopharmaceutical company that develops novel drugs for pain management and oncology. Website:

News & Commentary

AcelRx Should Trend Higher As FDA Approval Is Likely At End Of This Month

Oversold Conditions For Pain Therapeutics (PTIE)

Morning Coffee: Real-Time Picks

Pain Therapeutics (PTIE) Enters Overbought Territory - Tale of the Tape

SA PRO: Top Long And Short Ideas, Thursday February 27

10 Reasons To Buy Durect Right Now

Strength Seen in Pain Therapeutics Inc. (PTIE) Stock Surges 24% - Tale of the Tape

Can Nektar Therapeutics Beat Pfizer Inc.?

In addition to Remoxy, Pfizer has an in-house formulation of abuse-resistant oxycodone in late stage trials. Could an all new opioid from Nektar Therapeutics upend both programs?

Recent News At Durect Points To Bright Future

Elite Pharmaceuticals: Swinging For The Fences

See More PTIE News...

PTIE's Top Competitors

PTIE $5.02 (-3.09%)
Current stock: PTIE
JNJ $105.80 (-0.23%)
Current stock: JNJ
NVS $89.81 (-0.29%)
Current stock: NVS
RHHBY $36.86 (-1.18%)
Current stock: RHHBY